Monte Carlo estimates of natural variation in HIV infection

Journal of Theoretical Biology

Volumn 236, Issue 2, 2005, Pages 137-153

  Heffernan, Jane M ^a   Wahl, Lindi M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CD4+ cell count; HIV; Monte Carlo simulation; Variability in infection; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

HUMAN IMMUNODEFICIENCY VIRUS; MONTE CARLO ANALYSIS;

ARTICLE; CELL SURVIVAL; DISEASE SIMULATION; EXPOSURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; INOCULATION; LYMPHOCYTE COUNT; MATHEMATICAL MODEL; MONTE CARLO METHOD; PLASMA VOLUME; PREDICTION; PRIORITY JOURNAL; PROBABILITY; STOCHASTIC MODEL; T LYMPHOCYTE; VARIANCE; VIRION; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL DEATH; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MODELS, BIOLOGICAL; MONTE CARLO METHOD; T-LYMPHOCYTES; VIRAL LOAD; VIRION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21744447344     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtbi.2005.03.002     Document Type: Article

References (48)

1. R.M. Anderson, and R.M. May Epidemiology parameters of HIV transmission Nature 333 1988 514
2. R.M. Anderson, and R.M. May Infectious Diseases of Humans: Dynamics and Control 1991 Oxford University Press Oxford
3. Barth-Jones, D.C., Adams, A.L., Koopman, J.S., 2000. Monte Carlo simulations experiments for analysis of HIV vaccine effects and vaccine trial design. In: Joines, J.A., Barton, R.R., Kang, K., Fishwick, P.A. (Eds.), Proceedings of the 2000 Winter Simulation Conference, 1985-1994.
4. D.J. Covert, and D. Kirschner Revisiting early models of the host-pathogen interactions in HIV infection Comment Theor. Biol. 5 6 2000 383 411
5. da Silva, J., Hughes, A., 2002. Monte Carlo simulation of HIV-1 evolutions in response to selection by antibodies. IPDPS 2002.
6. S.G. Deeks, R.L. Coleman, R. White, C. Pachl, M. Schambelan, D.N. Chernoff, and M.B. Feinberg Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days J. Infect. Dis. 176 1997 514 517
7. G.L. Drusano, D.Z. Argenio, S.L. Preston, C. Barone, W. Symonds, S. LaFon, M. Rogers, W. Prince, A. Bye, and J.A. Bilello Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of Abacavir and Amprenavir Antimicrob. Agents Chemother. 44 6 2000 1655 1659
8. R.J. Gallop, C.J. Mode, and C.K. Sleeman Determination of threshold conditions for a non-linear stochastic partnership model for heterosexually transmitted diseases with stages Math. Biosci. 177 & 178 2002 287 315
9. A.T. Haase, K. Henry, M. Zupancic, G. Sedgewick, R.A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z-Q. Zhang, P.J. Dailey, H.H. Balfour Jr., A. Erice, and A.S. Perelson Quantitative image analysis of HIV-1 infection in lymphoid tissue Science 274 1996 985 989
10. D.D. Ho, A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 6510 1995 123 126
11. Y. Huang, S.L. Rosenkranz, and H. Wu Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity Math. Biosci. 184 2003 165 186
12. M.D. Hughes, D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair, and P.A. Volberding Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring J. Infect. Dis. 169 1994 28 36
13. N.M. Josuttis The C++ Standard Library 1999 Addison-Wesley Boston
14. A. Kamina, R.W. Makuch, and H. Zhao A stochastic modeling of early HIV-1 population dynamics Math. Biosci. 170 2001 187 198
15. P. Klenerman, R.E. Phillips, C.R. Rinaldo, L.M. Wahl, G. Ogg, R.M. May, A.J. McMichael, and M.A. Nowak Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection Proc. Natl Acad. Sci. USA 93 1996 15323 15328
16. Kousignian, I., Autran, B., Chouquet, C., Calvez, V., Gomard, E., Katlama, C., Riviere, Y., The IMMUNOCO Study group, Costagliola, D., 2003. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients. Stat. Med. 22, 1675-1690.
17. J.A. Levy, B. Ramachandran, E. Barker, J. Guthrie, T. Elbeik, and J.M. Coffin Plasma viral load, CD 4 + cell counts, and HIV-1 production by cells Science 271 5249 1996 670 671
18. A.L. Lloyd The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data Proc. R. Soc. Lond. B 268 2001 847 854
19. A.L. Lloyd Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics Theor. Popul. Biol. 60 2001 59 71
20. G. Macdonald The analysis of equilibrium in malaria Trop. Dis. Bull. 49 1952 813 829
21. A.R. McLean, and M.A. Nowak Competition between zidovudine sensitive and resistant strains of HIV AIDS 6 1992 71
22. A.R. McLean, V.C. Emery, A. Webster, and P.D. Griffiths Population dynamics of HIV within an individual after treatment with zidovudine AIDS 5 1991 485
23. S.J. Merrill Modeling the interaction of HIV with cells of the immune system Lecture Notes Biomath. 83 1989 371 385
24. C.J. Mode, and C.K. Sleeman An algorithmic synthesis of the deterministic and stochastic paradigms via computer intensive methods Math. Biosci. 180 2002 115 126
25. P.W. Nelson, M.A. Gilchrist, D. Coombs, J.M. Hyman, and A.S. Perelson An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells Math. Biosci. 1 2004 267 288
26. M.T. Niu, D.S. Stein, and S.M. Schnittman Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections J. Infect. Dis. 168 1993 1490 1501
27. M.A. Nowak, and R.M. May Virus Dynamics 2000 Oxford University Press Oxford
28. M.A. Nowak, A.L. Lloyd, G.M. Vasquez, T.A. Wiltrout, L.M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A.S. Fauci, W.M. Hirsch, and J.D. Lifson Viral dynamics of primary viremia and antiretroviral therapy in Simian Immunodeficiency Virus infection J. Virol. 71 1997 7518 7525
29. A.S. Perelson Modelling viral and immune system dynamics Nat. Rev: Immunol. 2 2002 28 36
30. A.S. Perelson, and P.W. Nelson Mathematical analysis of HIV-1 dynamics in vivo SIAM Rev. 41 1999 3
31. A.S. Perelson, D.E. Kirschner, and R.D. Boer Dynamics of HIV infection of CD4+ T-cells Math. Biosci. 114 1993 81
32. A.S. Perelson, A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time Science 271 1996 1582 1585
33. A.N. Phillips, M. Youle, M. Johnson, and C. Loveday Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development AIDS 15 2001 2211 2220
34. V. Piguet, O. Schwartz, S.L. Gall, and D. Trono The downregulation of CD4 and MHC-1 by primate lentiviruses: a paradigm for the modulation of cell surface receptors Immunol. Rev. 168 1999 51 63
35. W.H. Press, B.P. Flannery, S.A. Teukolsky, and W.T. Vetterling Numerical Recipes in C 1992 Cambridge University Press Cambridge
36. J.M. Raboud, J.S. Montaner, B. Conway, L. Haley, C. Sherlock, M.V. O'Shaughnessy, and M.T. Schechter Variation in Plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection J. Infect. Dis. 174 1996 191 194
37. S.S. Rhee, and J.W. Marsh Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization of and degradation of surface CD4 J. Virol. 68 8 1994 5156 5163
38. H.J. Ruskin, R.B. Pandey, and Y. Liu Viral load and stochastic mutation in a Monte Carlo simulation of HIV Physica A 311 2002 213 220
39. M. Sale, B.M. Sadler, and D.S. Stein Pharmacokinetic modeling and simulations of interaction of Amprenavir and Ritonavir Antimicrob. Agents Chemother. 46 3 2002 746 754
40. R. Smith, and L.M. Wahl Distinct effect of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infections with impulsive drug effects Bull. Math. Bio. 66 2004 1259 1283
41. Smith, R., Wahl, L.M., 2005. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects. Bull. Math. Bio., in press.
42. W.-Y. Tan, and H. Wu Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies Math. Biosci. 147 1998 173 205
43. M. Tanaka, T. Ueno, T. Nakahara, K. Sasaki, A. Ishimoto, and H. Sakai Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1 Virology 311 2003 316 325
44. H.C. Tuckwell, and E. Le Corfec A stochastic model for early HIV-1 population dynamics J. Theor. Biol. 195 1998 451 463
45. L.M. Wahl, and M.A. Nowak Adherence and drug resistance: predictions for therapy outcome Proc. R. Soc. Lond. B 267 2000 835 843
46. L.M. Wei, S.K. Ghosh, M.E. Taylor, V.A. Hohnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, M.S. Saag, and G.M. Shaw Viral dynamics in HIV-1 infection Nature 373 1995 117 122
47. R.L. Willey, F. Maldarelli, M.A. Martin, and K. Strebel Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 J. Virol. 66 12 1992 7193 7200
48. H. Wu, and A.A. Ding Population HIV-1 dynamics in vivo: applicable models and inferential tool for virological data from AIDS clinical trials Biometrics 55 1999 410 418